PATENT CLAIM ANALYSIS

Application Number: 16297316
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "04400A"]

Abstract:
This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Claim (Index 86):
A double stranded nucleic acid (dsNA), wherein the dsNA comprises:\n (a) a first nucleic acid strand, wherein:\n (i) the first nucleic acid strand is 15-27 nucleotides in length; and \n (ii) the first nucleic acid strand comprises one or more modified nucleotides; and \n (b) a second nucleic acid strand, wherein:\n (i) the second nucleic acid strand is 19-27 nucleotides in length; \n (ii) the second nucleic acid strand comprises one or more modified nucleotides; and \n (iii) the second nucleic acid strand is complementary to SEQ ID NO: 1823 along at least 19 consecutive nucleotides in length.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15616254', '14583200', '15793441', '16297354', '15102181']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.907686786541418
- 35 USC 102 Novelty (BERT): 0.6931937618830842
- Combined Prediction Score: 0.8862374840755847
- Mean Citation Score: 891.0236259999997
- Max Citation Score: 948.5961
- Similarity Product: 690.6098357516347

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test